Opinion|Videos|December 23, 2024
Evaluating Cognitive Health: Tools, Markers, and the Concept of Cognitive PIRA
Panelists discuss how clinicians can evaluate cognitive health using neuroimaging, cerebrospinal fluid (CSF)/blood biomarkers, and comprehensive assessments. Understanding concepts like cognitive progressive irreversible reductions in activity (PIRA) and focusing on multifaceted interventions—including lifestyle modifications, early detection, and personalized strategies—can help maintain cognitive wellness and mitigate decline.
Advertisement
Video content above is prompted by the following:
- Which tools, imaging, CSF, or peripheral blood markers can clinicians use to evaluate cognitive health in a patient? Please explain.
- What are your thoughts about the concept of cognitive PIRA?
- What advice would you have for health care providers so they can help patients better maintain their cognitive health?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Stem Cells of Secondary Progressive Multiple Sclerosis Drive Increased Proinflammatory T-Cell Activity
2
Postmortem Analysis Reveals Distinct Patterns of Aquaporin-4 in Parkinson Disease and Multiple System Atrophy
3
EMA Approves Semaglutide as First GLP-1 RA for Cardiovascular, Stroke-Related Benefits
4
Optimizing Speech and Movement Therapy to Improve Motor and Nonmotor Symptoms of Parkinson Disease: Cynthia Fox, PhD, CCC-SLP
5